Does the lymph node yield affect survival in patients with esophageal cancer receiving neoadjuvant therapy plus esophagectomy? A systematic review and updated meta-analysis

Background: Conflicting data have been reported on the prognostic impact of the extent of lymphadenectomy during esophagectomy for esophageal cancer (EC) after neoadjuvant therapy, especially after neoadjuvant chemoradiotherapy (nCRT). Methods: A comprehensive online search was performed to explore...

Full description

Bibliographic Details
Main Authors: Donglai Chen, Yiming Mao, Yuhang Xue, Yonghua Sang, Desen Liu, Yongbing Chen
Format: Article
Language:English
Published: Elsevier 2020-08-01
Series:EClinicalMedicine
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2589537020301759
_version_ 1819112912097116160
author Donglai Chen
Yiming Mao
Yuhang Xue
Yonghua Sang
Desen Liu
Yongbing Chen
author_facet Donglai Chen
Yiming Mao
Yuhang Xue
Yonghua Sang
Desen Liu
Yongbing Chen
author_sort Donglai Chen
collection DOAJ
description Background: Conflicting data have been reported on the prognostic impact of the extent of lymphadenectomy during esophagectomy for esophageal cancer (EC) after neoadjuvant therapy, especially after neoadjuvant chemoradiotherapy (nCRT). Methods: A comprehensive online search was performed to explore the association between increased lymph node yield (LNY) and survival of patients with EC, in which the overall survival (OS) was set as the primary outcome. In addition to analysis of the entire cohort, subgroup analyses of different induction therapy and different populations were also performed. Findings: A total of 19528 patients from twelve studies were included in our study. The pooled data revealed that more lymph node harvested was associated with better OS (HR = 0·87; 95% CI: 0·79–0·95, p < 0·001). Notably, a higher LNY was associated with better OS if the threshold was less than 18. However, more thorough lymphadenectomy might not bring additional survival benefits when it came to a cutoff value more than 18. The subgroup analysis further revealed that a higher LNY after nCRT was associated favorable survival. In terms of subset analysis of different populations, increased LNY was associated with longer OS in Western populations but not in Eastern. Interpretation: Increased LNY during esophagectomy after neoadjuvant therapy, especially after nCRT, might be associated with improved OS. More studies are warranted to assess the survival benefits of a higher LNY receiving neoadjuvant therapy plus esophagectomy, especially in Eastern populations. Funding: Supported by the projects from Suzhou Key Laboratory of Thoracic Oncology (SZS201907), Suzhou Key Discipline for Medicine (SZXK201803), the Science and Technology Research Foundation of Suzhou Municipality (SYS2018063, SYS2018064), Municipal Program of People's Livelihood Science and Technology in Suzhou (SS2019061) and Major Project for Social Development, Jiangsu Provincial Department of Science and Technology (SBE2020750085).
first_indexed 2024-12-22T04:21:02Z
format Article
id doaj.art-047e4630fe044f15a61c3644362d75f7
institution Directory Open Access Journal
issn 2589-5370
language English
last_indexed 2024-12-22T04:21:02Z
publishDate 2020-08-01
publisher Elsevier
record_format Article
series EClinicalMedicine
spelling doaj.art-047e4630fe044f15a61c3644362d75f72022-12-21T18:39:17ZengElsevierEClinicalMedicine2589-53702020-08-0125100431Does the lymph node yield affect survival in patients with esophageal cancer receiving neoadjuvant therapy plus esophagectomy? A systematic review and updated meta-analysisDonglai Chen0Yiming Mao1Yuhang Xue2Yonghua Sang3Desen Liu4Yongbing Chen5Department of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, ChinaDepartment of Thoracic Surgery, Suzhou Kowloon Hospital Shanghai Jiaotong University School of Medicine, Suzhou, ChinaDepartment of Thoracic Surgery, The Second Affiliated Hospital of Soochow University, Suzhou, ChinaDepartment of Thoracic Surgery, The Second Affiliated Hospital of Soochow University, Suzhou, China; Corresponding authors.Department of Thoracic Surgery, Suzhou Kowloon Hospital Shanghai Jiaotong University School of Medicine, Suzhou, China; Corresponding authors.Department of Thoracic Surgery, The Second Affiliated Hospital of Soochow University, Suzhou, China; Corresponding author.Background: Conflicting data have been reported on the prognostic impact of the extent of lymphadenectomy during esophagectomy for esophageal cancer (EC) after neoadjuvant therapy, especially after neoadjuvant chemoradiotherapy (nCRT). Methods: A comprehensive online search was performed to explore the association between increased lymph node yield (LNY) and survival of patients with EC, in which the overall survival (OS) was set as the primary outcome. In addition to analysis of the entire cohort, subgroup analyses of different induction therapy and different populations were also performed. Findings: A total of 19528 patients from twelve studies were included in our study. The pooled data revealed that more lymph node harvested was associated with better OS (HR = 0·87; 95% CI: 0·79–0·95, p < 0·001). Notably, a higher LNY was associated with better OS if the threshold was less than 18. However, more thorough lymphadenectomy might not bring additional survival benefits when it came to a cutoff value more than 18. The subgroup analysis further revealed that a higher LNY after nCRT was associated favorable survival. In terms of subset analysis of different populations, increased LNY was associated with longer OS in Western populations but not in Eastern. Interpretation: Increased LNY during esophagectomy after neoadjuvant therapy, especially after nCRT, might be associated with improved OS. More studies are warranted to assess the survival benefits of a higher LNY receiving neoadjuvant therapy plus esophagectomy, especially in Eastern populations. Funding: Supported by the projects from Suzhou Key Laboratory of Thoracic Oncology (SZS201907), Suzhou Key Discipline for Medicine (SZXK201803), the Science and Technology Research Foundation of Suzhou Municipality (SYS2018063, SYS2018064), Municipal Program of People's Livelihood Science and Technology in Suzhou (SS2019061) and Major Project for Social Development, Jiangsu Provincial Department of Science and Technology (SBE2020750085).http://www.sciencedirect.com/science/article/pii/S2589537020301759Esophageal cancerLymph nodesNeoadjuvant therapySurgeryPrognosis
spellingShingle Donglai Chen
Yiming Mao
Yuhang Xue
Yonghua Sang
Desen Liu
Yongbing Chen
Does the lymph node yield affect survival in patients with esophageal cancer receiving neoadjuvant therapy plus esophagectomy? A systematic review and updated meta-analysis
EClinicalMedicine
Esophageal cancer
Lymph nodes
Neoadjuvant therapy
Surgery
Prognosis
title Does the lymph node yield affect survival in patients with esophageal cancer receiving neoadjuvant therapy plus esophagectomy? A systematic review and updated meta-analysis
title_full Does the lymph node yield affect survival in patients with esophageal cancer receiving neoadjuvant therapy plus esophagectomy? A systematic review and updated meta-analysis
title_fullStr Does the lymph node yield affect survival in patients with esophageal cancer receiving neoadjuvant therapy plus esophagectomy? A systematic review and updated meta-analysis
title_full_unstemmed Does the lymph node yield affect survival in patients with esophageal cancer receiving neoadjuvant therapy plus esophagectomy? A systematic review and updated meta-analysis
title_short Does the lymph node yield affect survival in patients with esophageal cancer receiving neoadjuvant therapy plus esophagectomy? A systematic review and updated meta-analysis
title_sort does the lymph node yield affect survival in patients with esophageal cancer receiving neoadjuvant therapy plus esophagectomy a systematic review and updated meta analysis
topic Esophageal cancer
Lymph nodes
Neoadjuvant therapy
Surgery
Prognosis
url http://www.sciencedirect.com/science/article/pii/S2589537020301759
work_keys_str_mv AT donglaichen doesthelymphnodeyieldaffectsurvivalinpatientswithesophagealcancerreceivingneoadjuvanttherapyplusesophagectomyasystematicreviewandupdatedmetaanalysis
AT yimingmao doesthelymphnodeyieldaffectsurvivalinpatientswithesophagealcancerreceivingneoadjuvanttherapyplusesophagectomyasystematicreviewandupdatedmetaanalysis
AT yuhangxue doesthelymphnodeyieldaffectsurvivalinpatientswithesophagealcancerreceivingneoadjuvanttherapyplusesophagectomyasystematicreviewandupdatedmetaanalysis
AT yonghuasang doesthelymphnodeyieldaffectsurvivalinpatientswithesophagealcancerreceivingneoadjuvanttherapyplusesophagectomyasystematicreviewandupdatedmetaanalysis
AT desenliu doesthelymphnodeyieldaffectsurvivalinpatientswithesophagealcancerreceivingneoadjuvanttherapyplusesophagectomyasystematicreviewandupdatedmetaanalysis
AT yongbingchen doesthelymphnodeyieldaffectsurvivalinpatientswithesophagealcancerreceivingneoadjuvanttherapyplusesophagectomyasystematicreviewandupdatedmetaanalysis